Combination of Metformin With Gefitinib to Treat NSCLC
Status:
Completed
Trial end date:
2018-06-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether metformin in combination with gefitinib are
effective in patients with previously untreated advanced or metastatic Non-Small-Cell Lung
cancer with epidermal growth factor receptor (EGFR) mutations
Phase:
Phase 2
Details
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University